Pulmonary arterial hypertension in adult patients with congenital heart disease

Thesis

Cover

Title pages

Contents

Chapter 1: Introduction and outline of the thesis

Chapter 2: Pulmonary arterial hypertension in congenital heart disease : an epidemiologic perspective from a Dutch registry

Chapter 3: Pulmonary arterial hypertension in adults born with a heart septal defect : the Euro Heart Survey on adult congenital heart disease

Chapter 4: Pulmonary arterial hypertension associated with a congenital heart defect : advanced medium-term medical treatment stabilizes clinical condition

Chapter 5: Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt : does the beneficial effect persist?

Chapter 6: Down patients with Eisenmenger syndrome : is bosentan treatment an option?

Chapter 7: Effect of bosentan on exercise capacity and quality of life in adults with pulmonary arterial hypertension associated with congenital heart disease with and without Down’s syndrome

Chapter 8: Bosentan in patients with pulmonary arterial hypertension : a comparison between congenital heart disease and chronic pulmonary thromboembolism

Chapter 9: Why six-minute walk test is not an appropriate endpoint in mildly symptomatic pulmonary hypertension patients

Chapter 10: Duration of right ventricular contraction predicts the efficacy of bosentan treatment in patients with pulmonary hypertension?

Chapter 11: Atherosclerosis in patients with cyanotic congenital heart disease

Chapter 12: Summary & samenvatting

Dankwoord

Curriculum vitae

Stellingen